French ⋅ German ⋅ Italian ⋅ Portuguese ⋅ Russian ⋅ Spanish ⋅ Japanese  

  
  Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
A Better Way to Prevent Deadly Blood Clots?
Published: October 15, 2012.  by  Johns Hopkins Medicine

A computerized checklist system designed to help physicians identify and use the best methods of preventing potentially deadly blood clots in hospitalized trauma patients dramatically reduced the number of these dangerous venous thromboembolisms (VTEs), new Johns Hopkins research suggests.

Related Content
External link to Johns Hopkins Medicine
More news from Johns Hopkins Medicine

When a doctor enters medical orders for such patients, the automated checklist recommends evidence-based best treatments for each patient's needs, usually the regular administration of low-dose blood thinners or the use of compression devices to keep blood flowing in the legs. The researchers say this new system worked far better than previous methods, which included handing out laminated cards outlining best practices or lectures presented on the topic of preventing VTE, a term that covers dangerous clots in the legs and lungs.

The research team found a nearly two-fold improvement in prophylaxis orders among patients who had no contraindications to receiving the low-dose blood thinners. Blood thinners are often not ordered in patients with bleeding risk, as they can exacerbate bleeding.

While the rate of clots in the lungs, called pulmonary emboli, or PE events, stayed steady throughout study period, the researchers found the rate of DVT (deep vein thrombosis) in legs dropped nearly 90 percent, from 2.26 percent of trauma patients to 0.25 percent of trauma patients in the final year of the study. Though the size of the study was small, Haut and his team say the research shows that getting doctors to order the correct treatment is a key to reducing this major type of preventable harm to patients.

"VTE hits all segments of the population," says Elliott R. Haut, M.D., an associate professor of surgery at the Johns Hopkins University School of Medicine, and leader of the study described in the October issue of Archives of Surgery. "All hospitalized patients are at risk for this complication, and a huge number of these deadly clots are preventable if we give patients the right prophylaxis. We tried education alone for years and still only 40 to 60 percent of patients were getting optimal treatment. With this computerized system, we have made great strides toward making sure every patient gets exactly what he or she needs."

More than 600,000 people get a VTE each year in the United States and one in six die as a result, more than the number who die annually from breast cancer, AIDS or in car crashes. In 2008, the U.S. Surgeon General made a call to action to prevent DVT and PE. The Agency for Healthcare Research and Quality (AHRQ) has called appropriate prophylaxis the number one patient safety initiative needed to prevent in-hospital death.

As part of the study, Johns Hopkins computer programmers added a checklist for appropriate VTE prophylaxis to the hospital's computerized health records system. After information is input about the patient's case, the computer suggests appropriate treatment for prevention. Doctors can still override the system if they choose.

Before the checklist was put in place in January, 2008, records show that physicians at The Johns Hopkins Hospital offered the best prophylaxis to two-thirds of trauma patients, the researchers say. During the four-year implementation of the program, they found, 85 percent of the 1,599 trauma patients in the study received appropriate prophylaxis.

"It's a huge jump in doing right for patients," Haut says, but the goal is 100 percent.

Trauma patients are at a particularly high risk of developing DVT or PE, as risk factors for VTE include major surgery and extreme injury, especially to the spinal cord.

Haut says that many hospitals — including Johns Hopkins — have in recent years been giving nearly all of their patients some sort of prophylaxis for dangerous blood clots. But the problem, he says, is that patients don't always get as much treatment as they need and, in many cases, evidence-based best practices are not being followed.

Many hospitals say they give nearly all of their patients some type of VTE prophylaxis and that is true Haut says, but they often fail to give all that is necessary to prevent blood clots.

"The computerized tool makes ordering the right thing really easy," says Haut, a trauma surgeon on the core faculty of the Johns Hopkins Armstrong Institute for Patient Safety.

Haut says he understands that not every hospital has electronic health records up and running, but says the expense of adding the VTE checklist to existing electronic systems is minimal now that Hopkins has designed the program.



Show Footnotes »

Back to summary page »

Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish

Related Articles »
Vte 
6/23/10 
Risk Factors for Venous Thromboembolism And Pulmonary Embolism Differ Between Races; Study Shows True Causes Remain Unknown
Wiley - Blackwell
A new study of 1,960 White-Americans and 368 Black-Americans with objectively diagnosed venous thromboembolism (VTE) showed that, compared to Whites, Blacks had a significantly higher proportion with pulmonary embolism (PE), including idiopathic PE among Black women, and a significantly …
Vte 
6/23/10 
Risk Factors for Venous Thromboembolism And Pulmonary Embolism Differ Between Races
Wiley-Blackwell
A new study of 1,960 White-Americans and 368 Black-Americans with objectively diagnosed venous thromboembolism (VTE) showed that, compared to Whites, Blacks had a significantly higher proportion with pulmonary embolism (PE), including idiopathic PE among Black women, and a significantly …
Risk 
9/9/10 
Improvement in Prediction of Blood Clots in Cancer Patients
American Society of Hematology
(WASHINGTON, September 9, 2010) – For cancer patients, who have an increased risk of developing venous thromboembolism (VTE) due to a hyperactive blood coagulation system, there is now an enhanced risk model to predict their chance of developing blood …
Vte 
11/1/11 
ACP Recommends New Approach to Prevent Venous Thromboembolism in Hospitalized Patients
American College of Physicians
In a new clinical practice guideline published today in Annals of Internal Medicine, the American College of Physicians (ACP) recommends that doctors assess the risk of thromboembolism and bleeding in patients hospitalized for medical illnesses, including stroke, before initiating …
Vte 
1/16/13 
Surgical-site Infections May Increase Risk of Deadly Blood Clots After Colorectal Surgery
Johns Hopkins Medicine
Despite receiving blood thinners and other clot prevention treatment, some patients still develop potentially lethal blood clots in the first month after their operations anyway, especially if they developed a surgical-site infection while in the hospital, according to results …
Patients 
8/17/11 
Common Vein Condition Increases Risk for Developing Life-threating Blood Clots
American Society of Hematology
(WASHINGTON, August 17, 2011) –Patients with clinically diagnosed superficial vein thrombosis (SVT), a blood clot in the veins just beneath the skin that commonly resolves on its own without treatment, are four to six times more likely to develop …
Statins 
5/16/10 
Statins Decrease Risk of Clot-related Diseases
American Thoracic Society
ATS 2010, NEW ORLEANS— Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut. The results of the study will …
Fondaparinux 
7/7/11 
Cancer Patients with Blood Clots Gain No Benefit from Adding IVCF to Fondaparinux
International Association for the Study of Lung Cancer
Cancer patients with blood clots -- which occur in one of every 200 cancer patients and are the second most common cause of death among cancer patients -- gain no benefit from the insertion of an inferior vena cava …
More » 
Most Popular - Medicine »
MYELOMA »
Possible Treatment for Serious Blood Cancer
A single antibody could be the key to treating multiple myeloma, or cancer of the blood, currently without cure or long-term treatment. "We tested the antibody in various …
BREASTFEEDING »
Can Breastfeeding Protect Against ADHD?
INFECTIONS »
CLABSI Prevention Efforts Result in Up to 200,000 Infections Prevented in Intensive Care Units
CHICAGO (May 13, 2013) – New research from the Centers for Disease Control and Prevention (CDC) estimates that as many as 200,000 central line-associated bloodstream infections (CLABSIs) have been …
HDL »
Jekyll into Hyde: Breathing Auto Emissions Turns HDL Cholesterol from 'Good' to 'Bad'
Academic researchers have found that breathing motor vehicle emissions triggers a change in high-density lipoprotein (HDL) cholesterol, altering its cardiovascular protective qualities so that it actually contributes to clogged …
ADHD »
Long-term ADHD Treatment Increases Brain Dopamine Transporter Levels, May Affect Drug Efficacy
Long-term treatment of attention deficit/hyperactivity disorder (ADHD) with certain stimulant medications may alter the density of the dopamine transporter, according to research published May 15 in the open access …
ScienceNewsline.com  |  About  |  Privacy Policy  |  Feedback  |  Mobile
All contents are copyright of their owners except U.S. Government works. U.S. Government works are assumed to be in the public domain unless otherwise noted. Everything else copyright ScienceNewsline.com.